"Aspiration While Under Anesthesia" and "Perioperative Hyperglycemia Management"

Needs Statement

Physicians, faculty, anesthesiologists, fellows, residents and medical students at Baylor College of Medicine need to be regularly updated with new advances and guidelines in anesthesiology to increase clinical knowledge, and implement them in clinical practice to improve competence and enhance the quality of patient care and outcomes.

Educational Objectives

"Aspiration While Under Anesthesia"

At the conclusion of the session, the participants should be able to:

• Identify patients at risk of perioperative aspiration.
• Assess and implement interventions to decrease the risk of perioperative aspiration.
• Recognize the complications of aspiration.
• Apply the Ben Taub guidelines for patients at high risk of aspiration.

"Perioperative Hyperglycemia Management"

At the conclusion of the session, the participants should be able to:

• Recognize the importance of glucose control during the perioperative period.
• Apply knowledge of glucose control to manage hyperglycemia.
• Locate the appropriate protocol and order sets in the electronic medical record system.

Target Audience

Accreditation/Credit Designation

Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Baylor College of Medicine designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Policy

Baylor College of Medicine (BCM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. BCM is committed to sponsoring CE activities that are scientifically based, accurate, current, and objectively presented.

In accordance with the ACCME Standards for Commercial Support, BCM has implemented a mechanism requiring everyone in a position to control the content of an educational activity (i.e., directors, planning committee members, faculty) to disclose any relevant financial relationships with commercial interests (drug/device companies) and manage/resolve any conflicts of interest prior to the activity. Individuals must disclose to participants the existence or non-existence of financial relationships at the time of the activity or within 24 months prior.

In addition, BCM has requested activity faculty/presenters to disclose to participants any unlabeled use or investigational use of pharmaceutical/device products; to use scientific or generic names (not trade names) in referring to products; and, if necessary to use a trade name, to use the names of similar products or those within a class. Faculty/presenters have also been requested to adhere to the ACCME's validation of clinical content statements.

BCM does not view the existence of financial relationships with commercial interests as implying bias or decreasing the value of a presentation. It is up to participants to determine whether the relationships influence the activity faculty with regard to exposition or conclusions. If at any time during this activity you feel that there has been commercial/promotional bias, notify the Activity Director or Activity Coordinator. Please answer the questions about balance and objectivity in the activity evaluation candidly.

All of the relevant financial relationships listed for these individuals have been mitigated.